CNTX Stock Ownership Breakdown

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own CNTX shares is 38, representing 76.4% of the company's common stock.

CITADEL ADVISORS LLC, in the last quarter, reduced its stake in CNTX by -5.28% restricting it's holding to 15.04 thousand shares of worth nearly $20.76K. TOWER RESEARCH CAPITAL LLC (TRC) also lessened -4.48% of the CNTX shares from its portfolio, reducing its holding to 6.36 thousand shares of worth $8.77K. BANK OF AMERICA CORP /DE/ also shunned CNTX shares holding by -100% last quarter which brought its holding to 0 shares worth -.

As per its latest 13F filing, SUSQUEHANNA INTERNATIONAL GROUP, LLP increased its stake in CNTX by 100% in the last quarter. The institutional holder raised its holding to 22.39 thousand shares having worth more than $30.90K. JEFFERIES FINANCIAL GROUP INC. also added 100% more shares of CNTX to its portfolio, raising its holding to 11.45 thousand shares of worth $15.81K. XTX TOPCO LTD also increased its CNTX shares holding by 100% which brought its holding to 10.26 thousand shares worth $14.16K.

The insider with the most stakes in CNTX is Lehr Martin A. , Chief Executive Officer at the company. Additionally, CNTX stock is highly held by Chief Financial Officer Minai-Azary Jennifer Lynn and Chief Medical Officer Sahmoud Tarek among others.

Company executives, directors, and other insiders own 1.45% percent of Context Therapeutics Inc.'s stock. Within the last six months, there have been 0 transaction(s) in which CNTX insiders have sold stock, totaling 0 shares. Insiders that have sold shares include .

There have been 0 transaction(s) during the past 6-months in which Context Therapeutics Inc. insiders have bought stock, totalling 0 shares

Around 0 Context Therapeutics Inc. shares are held by insiders, which represents about 1.45% of CNTX stock.

CNTX Chief Executive Officer, Lehr Martin A. holds the largest portfolio of the company's shares. CNTX shares owned by Lehr total nearly 159.7 thousand.

SHEETS SMITH WEALTH MANAGEMENT is the largest institutional owner in CNTX which holds 20 thousand shares worth $27.60K or 0.13% of the total CNTX shares outstanding followed by CLEAR HARBOR ASSET MANAGEMENT, LLC with ownership of 36 thousand shares representing 0.23% of the CNTX ownership. SUSQUEHANNA INTERNATIONAL GROUP, LLP is the third largest stakeholder with 22.39 thousand shares or 0.14% of the ownership worth more than $30.90K.

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the CNTX is concerned, it is a stock which is not optionable.

Number of CNTX shares short is 1.03M. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

As of today, 75.00M shares of CNTX are outstanding.

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, CNTX has 39.07M shares in float.

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for CNTX is 2.79.